CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Thousands		Preferred Investment Options Common Shares	Preferred Investment Options Additional Paid-In Capital	Preferred Investment Options	Common Shares	Additional Paid-In Capital	Accumulated Deficit	Total
Balance at the beginning at Dec. 31, 2022	[1]					$ 46,204	$ (31,985)	$ 14,219
Balance at the beginning (in shares) at Dec. 31, 2022	[1]				15,190,720
CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS' EQUITY (DEFICIT)
Share-based payments						1,402		1,402
Issuance of restricted share awards (in shares)					585,499
Exercise of warrants			$ 39	$ 39		663		663
Exercise of warrants (in shares)		4,000			105,920
Net loss for the period							(4,049)	(4,049)
Balance at the end at Mar. 31, 2023						48,308	(36,034)	12,274
Balance at the end (in shares) at Mar. 31, 2023					15,886,139
Balance at the beginning at Dec. 31, 2022	[1]					46,204	(31,985)	14,219
Balance at the beginning (in shares) at Dec. 31, 2022	[1]				15,190,720
CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS' EQUITY (DEFICIT)
Net loss for the period								(9,757)
Balance at the end at Jun. 30, 2023						62,074	(41,742)	20,332
Balance at the end (in shares) at Jun. 30, 2023					17,221,113
Balance at the beginning at Mar. 31, 2023						48,308	(36,034)	12,274
Balance at the beginning (in shares) at Mar. 31, 2023					15,886,139
CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS' EQUITY (DEFICIT)
Issuance of common shares, net of offering costs						3,110		3,110
Issuance of common shares, net of offering costs (in shares)					188,970
Share-based payments						950		950
Issuance of restricted share awards (in shares)					63,000
Exercise of warrants			$ 8,852	$ 8,852		816		816
Exercise of warrants (in shares)		997,091			79,104
Exercise of share options						38		38
Exercise of share options (in shares)					6,809
Net loss for the period							(5,708)	(5,708)
Balance at the end at Jun. 30, 2023						62,074	(41,742)	20,332
Balance at the end (in shares) at Jun. 30, 2023					17,221,113
Balance at the beginning at Dec. 31, 2023						66,446	(54,245)	12,201
Balance at the beginning (in shares) at Dec. 31, 2023					17,418,886
CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS' EQUITY (DEFICIT)
Issuance of common shares, net of offering costs						4,696		4,696
Issuance of common shares, net of offering costs (in shares)					502,647
Share-based payments						1,296		1,296
Issuance of restricted share awards (in shares)					434,527
Net loss for the period							(4,171)	(4,171)
Balance at the end at Mar. 31, 2024						72,438	(58,416)	14,022
Balance at the end (in shares) at Mar. 31, 2024					18,356,060
Balance at the beginning at Dec. 31, 2023						66,446	(54,245)	12,201
Balance at the beginning (in shares) at Dec. 31, 2023					17,418,886
CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS' EQUITY (DEFICIT)
Net loss for the period								(8,599)
Balance at the end at Jun. 30, 2024						75,372	(62,844)	12,528
Balance at the end (in shares) at Jun. 30, 2024					18,748,751
Balance at the beginning at Mar. 31, 2024						72,438	(58,416)	14,022
Balance at the beginning (in shares) at Mar. 31, 2024					18,356,060
CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS' EQUITY (DEFICIT)
Issuance of common shares, net of offering costs						1,672		1,672
Issuance of common shares, net of offering costs (in shares)					246,691
Share-based payments						1,262		1,262
Issuance of restricted share awards (in shares)					146,000
Net loss for the period							(4,428)	(4,428)
Balance at the end at Jun. 30, 2024						$ 75,372	$ (62,844)	$ 12,528
Balance at the end (in shares) at Jun. 30, 2024					18,748,751

[1] Represents an amount lower than $1,000 USD.